|
1
|
Wagner J, Rapsomaniki MA, Chevrier S,
Anzeneder T, Langwieder C, Dykgers A, Rees M, Ramaswamy A, Muenst
S, Soysal SD, et al: A single-cell atlas of the tumor and immune
ecosystem of human breast cancer. Cell. 177:1330–1345 e1318. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ciriello G, Gatza ML, Beck AH, Wilkerson
MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, et
al: Comprehensive molecular portraits of invasive lobular breast
cancer. Cell. 163:506–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jung SY, Rosenzweig M, Sereika SM, Linkov
F, Brufsky A and Weissfeld JL: Factors associated with mortality
after breast cancer metastasis. Cancer Causes Control. 23:103–112.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li XH, Song JW, Liu JL, Wu S, Wang Ls,
Gong Ly and Lin X: Serine-Arginine protein kinase 1 is associated
with breast cancer progression and poor patient survival. Med
Oncol. 31:832014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu J and Thompson CB: Metabolic
regulation of cell growth and proliferation. Nat Rev Mol Cell Biol.
20:436–450. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kamphorst JJ and Gottlieb E: Cancer
metabolism: Friendly neighbours feed tumour cells. Nature.
536:401–402. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wagner EF and Petruzzelli M: Cancer
metabolism: A waste of insulin interference. Nature. 521:430–431.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tasselli L and Chua KF: Cancer: Metabolism
in ‘the driver's seat’. Nature. 492:362–363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao Y: Adipocyte and lipid metabolism in
cancer drug resistance. J Clin Invest. 129:3006–3017. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang IY, Ohn T, Ko GS, Yoon Y, Kim JW and
Yoon SP: Immunolocalization of steroidogenic acute regulatory
protein-related lipid transfer (START) domain-containing proteins
in the developing cerebellum of normal and hypothyroid rats. J Chem
Neuroanat. 43:28–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ishikawa T, Hwang K, Lazzarino D and
Morris PL: Sertoli cell expression of steroidogenic acute
regulatory protein-related lipid transfer 1 and 5 domain-containing
proteins and sterol regulatory element binding protein-1 are
interleukin-1beta regulated by activation of c-jun n-terminal
kinase and cyclooxygenase-2 and cytokine induction. Endocrinology.
146:5100–5111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clark BJ: The mammalian START domain
protein family in lipid transport in health and disease. J
Endocrinol. 212:257–275. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Soccio RE, Adams RM, Romanowski MJ,
Sehayek E, Burley SK and Breslow JL: The cholesterol-regulated
starD4 gene encodes a StAR-related lipid transfer protein with two
closely related homologues, starD5 and starD6. Proc Natl Acad Sci
USA. 99:6943–6948. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alpy F and Tomasetto C: Give lipids a
START: The StAR-related lipid transfer (START) domain in mammals. J
Cell Sci. 118:2791–2801. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Calderon-Dominguez M, Gil G, Medina MA,
Pandak WM and Rodríguez-Agudo D: The starD4 subfamily of
steroidogenic acute regulatory-related lipid transfer (START)
domain proteins: New players in cholesterol metabolism. Int J
Biochem Cell Biol. 49:64–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Riegelhaupt JJ, Waase MP, Garbarino J,
Cruz DE and Breslow JL: Targeted disruption of steroidogenic acute
regulatory protein D4 leads to modest weight reduction and minor
alterations in lipid metabolism. J Lipid Res. 51:1134–1143. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rodriguez-Agudo D, Ren S, Wong E, Marques
D, Redford K, Gil G, Hylemon P and Pandak WM: Intracellular
cholesterol transporter starD4 binds free cholesterol and increases
cholesteryl ester formation. J Lipid Res. 49:1409–1419. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Garbarino J, Pan M, Chin HF, Lund FW,
Maxfield FR and Breslow JL: STARD4 knockdown in hepG2 cells
disrupts cholesterol trafficking associated with the plasma
membrane, ER, and ERC. J Lipid Res. 53:2716–2725. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bouhaddou M, DiStefano MS, Riesel EA,
Carrasco E, Holzapfel HY, Jones DC, Smith GR, Stern AD, Somani SS,
Thompson TV and Birtwistle MR: Drug response consistency in CCLE
and CGP. Nature. 540:E9–E10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dey-Rao R, Smith JR, Chow S and Sinha AA:
Differential gene expression analysis in CCLE lesions provides new
insights regarding the genetics basis of skin vs. systemic disease.
Genomics. 104:144–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li T, Fan J, Wang B, Traugh N, Chen Q, Liu
JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis
of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gyorffy B, Lánczky A and Szállási Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li K, Ma YB, Zhang Z, Tian YH, Xu XL, He
YQ, Xu L, Gao Y, Pan WT and Song WJ: Upregulated IQUB promotes cell
proliferation and migration via activating
Akt/GSK3beta/beta-catenin signaling pathway in breast cancer.
Cancer Med. 7:3875–3888. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hammond ME, Hayes DF, Dowsett M, Allred
DC, Hagerty KL, Badve S, FitzgibbonsP L, Francis G, Goldstein NS,
Hayes M, et al: American society of clinical oncology/college of
american pathologists guideline recommendations for
immunohistochemical testing of estrogen and progesterone receptors
in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wolff AC, Hammond ME, Hicks DG, Dowsett M,
McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M,
Fitzgibbons P, et al: Recommendations for human epidermal growth
factor receptor 2 testing in breast cancer: American society of
clinical oncology/college of American pathologists clinical
practice guideline update. J Clin Oncol. 31:3997–4013. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dowsett M, Nielsen TO, A'Hern R, Bartlett
J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, et
al: Assessment of Ki67 in breast cancer: Recommendations from the
international Ki67 in breast cancer working group. J Natl Cancer
Inst. 103:1656–1664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang F, Liu H, Zhao J, Ma X and Qi W:
POLR1B is upregulated and promotes cell proliferation in non-small
cell lung cancer. Oncol Lett. 19:671–680. 2020.PubMed/NCBI
|
|
29
|
Wan X, Kong Z, Chu K, Yi C, Hu J, Qin R,
Zhao C, Fu F, Wu H, Li Y and Huang Y: Co-Expression analysis
revealed PTCH1-3′UTR promoted cell migration and invasion by
activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer:
Implicating the novel function of PTCH1. Oncotarget. 9:4798–4813.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cai Z, Sanchez A, Shi Z, Zhang T, Liu M
and Zhang D: Activation of toll-like receptor 5 on breast cancer
cells by flagellin suppresses cell proliferation and tumor growth.
Cancer Res. 71:2466–2475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu L, Wei Y, Zhou WB, Zhang YS, Chen QH,
Liu MX, Zhu ZP, Zhou J, Yang LH, Wang HM, et al: Gene expression
alterations of human liver cancer cells following borax exposure.
Oncol Rep. 42:115–130. 2019.PubMed/NCBI
|
|
33
|
Wang Z, Chen J, Zhong MZ, Huang J, Hu YP,
Feng DY, Zhou ZJ, Luo X, Liu ZQ, Jiang WZ and Zhou WB:
Overexpression of ANLN contributed to poor prognosis of
anthracycline-based chemotherapy in breast cancer patients. Cancer
Chemother Pharmacol. 79:535–543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou W, Wang Z, Shen N, Pi W, Jiang W,
Huang J, Hu Y, Li X and Sun L: Knockdown of ANLN by lentivirus
inhibits cell growth and migration in human breast cancer. Mol Cell
Biochem. 398:11–19. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou W, Guan X, Wang L, Liao Y and Huang
J: P12(CDK2-AP1) inhibits breast cancer cell proliferation and in
vivo tumor growth. J Cancer Res Clin Oncol. 138:2085–2093. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gandhi N and Das GM: Metabolic
reprogramming in breast cancer and its therapeutic implications.
Cells. 26:89019.
|
|
37
|
Davis KE, Neinast MD, Sun K, Skiles WM,
Bills JD, Zehr JA, Zeve D, Hahner LD, Cox DW, Gent LM, et al: The
sexually dimorphic role of adipose and adipocyte estrogen receptors
in modulating adipose tissue expansion, inflammation, and fibrosis.
Mol Metab. 2:227–242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Korytowski W, Rodriguez-Agudo D, Pilat A
and Girotti AW: StarD4-Mediated translocation of
7-hydroperoxycholesterol to isolated mitochondria: Deleterious
effects and implications for steroidogenesis under oxidative stress
conditions. Biochem Biophys Res Commun. 392:58–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Korytowski W, Wawak K, Pabisz P, Schmitt
JC, Chadwick AC, Sahoo D and Girotti AW: Impairment of macrophage
cholesterol efflux by cholesterol hydroperoxide trafficking:
Implications for atherogenesis under oxidative stress. Arterioscler
Thromb Vasc Biol. 35:2104–2113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Simigdala N, Gao Q, Pancholi S,
Roberg-Larsen H, Zvelebil M, Ribas R, Folkerd E, Thompson A, Bhamra
A, Dowsett M and Martin LA: Cholesterol biosynthesis pathway as a
novel mechanism of resistance to estrogen deprivation in estrogen
receptor-positive breast cancer. Breast Cancer Res. 18:582016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Munir MT, Ponce C, Powell CA, Tarafdar K,
Yanagita T, Choudhury M, Gollahon LS and Rahman SM: The
contribution of cholesterol and epigenetic changes to the
pathophysiology of breast cancer. J Steroid Biochem Mol Biol.
183:1–9. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He S and Nelson ER: 27-Hydroxycholesterol,
an endogenous selective estrogen receptor modulator. Maturitas.
104:29–35. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McDonnell DP, Chang CY and Nelson ER: The
estrogen receptor as a mediator of the pathological actions of
cholesterol in breast cancer. Climacteric. 17:60–65. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Iaea DB, Dikiy I, Kiburu I, Eliezer D and
Maxfield FR: STARD4 membrane interactions and sterol binding.
Biochemistry. 54:4623–4636. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rodriguez-Agudo D, Calderon-Dominguez M,
Ren S, Marques D, Redford K, Medina-Torres MA, Hylemon P, Gil G and
Pandak WM: Subcellular localization and regulation of starD4
protein in macrophages and fibroblasts. Biochim Biophys Acta.
1811:597–606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Garcia-Bermudez J and Birsoy K: Drugging
ACAT1 for cancer therapy. Mol Cell. 64:856–857. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Saraon P, Trudel D, Kron K,
Dmitromanolakis A, Trachtenberg J, Bapat B, van der Kwast T, Jarvi
KA and Diamandis EP: Evaluation and prognostic significance of
ACAT1 as a marker of prostate cancer progression. Prostate.
74:372–380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Antalis CJ, Arnold T, Rasool T, Lee B,
Buhman KK and Siddiqui RA: High ACAT1 expression in estrogen
receptor negative basal-like breast cancer cells is associated with
LDL-induced proliferation. Breast Cancer Res Treat. 122:661–670.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Oikawa T and Yamada T: Molecular biology
of the ets family of transcription factors. Gene. 303:11–34. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Xiao XH and He SY: ELF1 activated long
non-coding RNA CASC2 inhibits cisplatin resistance of non-small
cell lung cancer via the miR-18a/IRF-2 signaling pathway. Eur Rev
Med Pharmacol Sci. 24:3130–3142. 2020.PubMed/NCBI
|
|
51
|
Budka JA, Ferris MW, Capone MJ and
Hollenhorst PC: Common ELF1 deletion in prostate cancer bolsters
oncogenic ETS function, inhibits senescence and promotes docetaxel
resistance. Genes Cancer. 9:198–214. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fukushima T, Miyazaki Y, Tsushima H,
Tsutsumi C, Taguchi J, Yoshida S, Kuriyama K, Scadden D, Nimer S
and Tomonaga M: The level of MEF but not ELF-1 correlates with FAB
subtype of acute myeloid leukemia and is low in good prognosis
cases. Leukemia Res. 27:387–392. 2003. View Article : Google Scholar
|
|
53
|
Rao M, Zhu Y, Cong X and Li Q: Knockdown
of CREB1 inhibits tumor growth of human gastric cancer in
vitro and in vivo. Oncol Rep. 37:3361–3368. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sakamoto KM and Frank DA: CREB in the
pathophysiology of cancer: Implications for targeting transcription
factors for cancer therapy. Clin Cancer Res. 15:2583–2587. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shao Y, Qi Y, Huang Y, Liu Z, Ma Y, Guo X,
Jiang S, Sun Z and Ruan Q: Human cytomegalovirus miR-US4-5p
promotes apoptosis via downregulation of p21-activated kinase 2 in
cultured cells. Mol Med Rep. 16:4171–4178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Eron SJ, Raghupathi K and Hardy JA: Dual
site phosphorylation of caspase-7 by PAK2 blocks apoptotic activity
by two distinct mechanisms. Structure. 25:27–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Flate E and Stalvey JR: Motility of select
ovarian cancer cell lines: Effect of extra-cellular matrix proteins
and the involvement of PAK2. Int J Oncol. 45:1401–1411. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gao C, Ma T, Pang L and Xie R: Activation
of P21-activated protein kinase 2 is an independent prognostic
predictor for patients with gastric cancer. Diagn Pathol. 9:552014.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Park J, Kim JM, Park JK, Huang S, Kwak SY,
Ryu KA, Kong G, Park J and Koo BS: Association of p21-activated
kinase-1 activity with aggressive tumor behavior and poor prognosis
of head and neck cancer. Head Neck. 37:953–963. 2015. View Article : Google Scholar : PubMed/NCBI
|
